Therapeutic immunopharmacology
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 2 (2) , 258-263
- https://doi.org/10.1016/0952-7915(89)90197-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer Vaccines Show Promise at LastScience, 1989
- TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCERThe Lancet, 1989
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- FK-506 — How much potential?Immunology Today, 1989
- Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytesInternational Journal of Immunopharmacology, 1989
- Sodium diethyldithiocarbamate restores T lymphocyte proliferation, interleukin-2 production and NK activity in cyclophosphamide-immunosuppressed animalsImmunopharmacology, 1988
- The Role of Interferon in Cancer Therapy: A Current PerspectiveCA: A Cancer Journal for Clinicians, 1988
- Rationale for Recombinant Human Interferon-Gamma Adjuvant Immunotherapy for CancerJNCI Journal of the National Cancer Institute, 1988
- Immunomodulatory properties of cimetidine in ARC patientsClinical Immunology and Immunopathology, 1988
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988